NEW YORK (GenomeWeb) — Cancer Genetics (CGI) said today that it signed a distribution deal for its microarray gene expression Tissue of Origin test in China with GeneCast Biotechnology.

According to Rutherford, New Jersey-based CGI, the test is designed to analyze 2,000 individual tumor genes, covering 15 of the most common tumor types and 90 percent of all solid tumors, in order to help identify a malignancy's origin.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.